79 related articles for article (PubMed ID: 29199252)
21. Selenium supplementation in the critically ill: posology and pharmacokinetics.
Manzanares W; Hardy G
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):273-80. PubMed ID: 19333120
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations.
Lonsdale DO; Udy AA; Roberts JA; Lipman J
J Neurosurg; 2013 Feb; 118(2):297-301. PubMed ID: 23121433
[TBL] [Abstract][Full Text] [Related]
23. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium.
Brodska H; Valenta J; Malickova K; Kohout P; Kazda A; Drabek T
J Trace Elem Med Biol; 2015; 31():25-32. PubMed ID: 26004888
[TBL] [Abstract][Full Text] [Related]
26. Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
Fernández de Gatta MM; Fruns I; Domínguez-Gil A
Pharmacotherapy; 1994; 14(2):196-201. PubMed ID: 8197039
[TBL] [Abstract][Full Text] [Related]
27. Importance of Decision Support Implementation in Emergency Department Vancomycin Dosing.
Faine B; Mohr N; Harland KK; Rolfes K; Porter B; Fuller BM
West J Emerg Med; 2015 Jul; 16(4):557-64. PubMed ID: 26265968
[TBL] [Abstract][Full Text] [Related]
28. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
29. Influence of cerebral fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients.
Ichie T; Urano K; Suzuki D; Okada T; Kobayashi N; Hayashi H; Sugiura Y; Yamamura K; Sugiyama T
Pharmazie; 2015 Jun; 70(6):404-9. PubMed ID: 26189303
[TBL] [Abstract][Full Text] [Related]
30. Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model.
Hussain K; Ikram R; Ambreen G; Salat MS
J Pharm Policy Pract; 2021 Nov; 14(1):100. PubMed ID: 34847951
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic drug monitoring of phenytoin in critically ill patients.
von Winckelmann SL; Spriet I; Willems L
Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
[TBL] [Abstract][Full Text] [Related]
32. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Jamal JA; Udy AA; Lipman J; Roberts JA
Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
[TBL] [Abstract][Full Text] [Related]
33. Time to initial antibiotic administration, and short-term mortality among patients admitted with community-acquired severe infections with and without the presence of systemic inflammatory response syndrome: a follow-up study.
Henriksen DP; Laursen CB; Hallas J; Pedersen C; Lassen AT
Emerg Med J; 2015 Nov; 32(11):846-53. PubMed ID: 25762652
[TBL] [Abstract][Full Text] [Related]
34. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Laparoscopy in the Intensive Care Unit.
Zemlyak A; Heniford BT; Sing RF
J Intensive Care Med; 2015 Jul; 30(5):297-302. PubMed ID: 23761270
[TBL] [Abstract][Full Text] [Related]
36. Systemic and splanchnic metabolic response to exogenous human growth hormone.
Dahn MS; Lange MP
Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
[TBL] [Abstract][Full Text] [Related]
37. Pharmaconutrition with selenium in critically ill patients: what do we know?
Manzanares W; Langlois PL; Heyland DK
Nutr Clin Pract; 2015 Feb; 30(1):34-43. PubMed ID: 25524883
[TBL] [Abstract][Full Text] [Related]
38. Causes and consequences of fever complicating critical surgical illness.
Barie PS; Hydo LJ; Eachempati SR
Surg Infect (Larchmt); 2004; 5(2):145-59. PubMed ID: 15353111
[TBL] [Abstract][Full Text] [Related]
39. Rapid and Sustained Long-Term Decrease of Fecal Short-Chain Fatty Acids in Critically Ill Patients With Systemic Inflammatory Response Syndrome.
Yamada T; Shimizu K; Ogura H; Asahara T; Nomoto K; Yamakawa K; Hamasaki T; Nakahori Y; Ohnishi M; Kuwagata Y; Shimazu T
JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):569-77. PubMed ID: 24711120
[TBL] [Abstract][Full Text] [Related]
40. ADAMTS-13 in Critically Ill Patients With Septic Syndromes and Noninfectious Systemic Inflammatory Response Syndrome.
Aibar J; Castro P; Espinosa G; Fernández S; Hernández C; Rinaudo M; Butjosa M; Tàssies D; Reverter JC; Nicolás JM
Shock; 2015 Jun; 43(6):556-62. PubMed ID: 25643015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
